secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kiromic Biopharma, Inc. (—)
CIK:        0001792581
Form:       8-K
Filed at:   2023-03-17T23:59:59+00:00
Accession:  0001104659-23-034000
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiromic BioPharma receives Nasdaq delisting notice for bid price non-compliance; intends to request hearing
--------------------------------------------------------------------------------

- Nasdaq notified Kiromic on March 14, 2023 that it failed to regain minimum $1.00 bid price by March 13 grace period.
- Common stock (KRBP) scheduled for delisting on March 23, 2023 unless hearing is requested.
- Company intends to request hearing to stay delisting and present compliance plan.
- Hearing panel may also consider separate $2.5M stockholders' equity deficiency as additional basis for delisting.
- Panel can grant extension up to September 11, 2023; no assurance of continued listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1792581/000110465923034000/0001104659-23-034000-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1792581/000110465923034000/tm239172d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-034000

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer